Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

OmniAb, Inc. Director's Dealing 2024

Feb 21, 2024

35559_dirs_2024-02-20_0aeb5855-7246-4715-a040-a93d0f03aa7f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OmniAb, Inc. (OABI)
CIK: 0001846253
Period of Report: 2024-02-15

Reporting Person: Berkman Charles S (Chief Legal Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-02-15 Common Stock M 15624 Acquired 287941 Direct
2024-02-15 Common Stock F 5575 $5.54 Disposed 282366 Direct
2024-02-15 Common Stock M 5698 Acquired 288064 Direct
2024-02-15 Common Stock F 2034 $5.54 Disposed 286030 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-02-15 Restricted Stock Units $0.0 M 15624 Disposed Common Stock (15624) Direct
2024-02-15 Restricted Stock Units $0.0 M 5698 Disposed Common Stock (5698) Direct
2024-02-16 Restricted Stock Units $0.0 A 40625 Acquired Common Stock (40625) Direct
2024-02-16 Stock Option (right to buy) $5.64 A 243750 Acquired 2034-02-16 Common Stock (243750) Direct

Footnotes

F1: Represents the vesting of an RSU grant which occurs in three substantially equal annual installments beginning on February 15, 2023, as per the terms of the November 2022 Business Combination.

F2: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F3: Represents shares withheld to satisfy tax withholding obligations upon the vesting of previously reported RSUs.

F4: Represents the vesting of an RSU grant which occurs in two substantially equal annual installments beginning on February 15, 2023, as per the terms of the November 2022 Business Combination.

F5: The RSU grant vests in three substantially equal annual installments beginning on February 16, 2025.

F6: The Stock Option grant vests and is exercisable as to 12.5% of the underlying shares 6 months after the grant date, and in 42 substantially equal monthly installments thereafter.